Drug Repurposing News and Research

RSS
No excess mortality during the Delta variant era in US state with high vaccination rates

No excess mortality during the Delta variant era in US state with high vaccination rates

Potential covalent SARS-CoV-2 spike protein inhibitors

Potential covalent SARS-CoV-2 spike protein inhibitors

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

COVID-19 deaths in U.S. surpass 1918 Spanish Flu pandemic

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Impact of colloidal aggregation in COVID-19 drug repurposing screens

Impact of colloidal aggregation in COVID-19 drug repurposing screens

First pharmacological treatment option for patients with a severe form of epilepsy

First pharmacological treatment option for patients with a severe form of epilepsy

Existing drugs block or reduce SARS-CoV2 infection in cells

Existing drugs block or reduce SARS-CoV2 infection in cells

Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

New compound inspired by tapeworm drugs shows two-pronged effectiveness against COVID-19

New compound inspired by tapeworm drugs shows two-pronged effectiveness against COVID-19

Inhibition of SARS-CoV-2 replication in vitro by Losartan

Inhibition of SARS-CoV-2 replication in vitro by Losartan

Finding potential microRNAs from humans and plants against SARS-CoV-2

Finding potential microRNAs from humans and plants against SARS-CoV-2

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

Scientist explore conserved RNA elements as potential targets for anti-SARS-CoV-2 drugs

COVID-19 researchers review 184 drug repurposing candidates

COVID-19 researchers review 184 drug repurposing candidates

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

Discovery of SARS-CoV-2–induced pathways uncovers groundbreaking drug repurposing strategies

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

Plant compounds inhibit Mpro of SARS-CoV-2 and HCoV-229E in vitro

CRISPRa identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2

CRISPRa identifies potassium channels as neuronal entry factors and druggable targets for SARS-CoV-2

Varenicline blocks SARS-CoV-2 infection in cells and animal models

Varenicline blocks SARS-CoV-2 infection in cells and animal models

Study suggests vitamin B12 as a SARS-CoV-2 antiviral

Study suggests vitamin B12 as a SARS-CoV-2 antiviral

Researchers decode humans’ survival from historical coronavirus outbreaks

Researchers decode humans’ survival from historical coronavirus outbreaks